Zenas BioPharma (ZBIO) Other financing activities (2023 - 2026)

Zenas BioPharma's Other financing activities history runs 4 years deep, the most recent figure standing at $367000.0 for Q1 2026.

• On a quarterly basis, Other financing activities rose 270.71% year-over-year to $367000.0 in Q1 2026; TTM through Mar 2026 was $544000.0, a 99.79% decrease from a year earlier, with the FY2025 full-year figure at $276000.0, changed 0.36% from the prior year.
• Other financing activities advanced to $367000.0 in Q1 2026 per ZBIO's latest filing, from -$1.5 million in the prior quarter.
• Across five years, Other financing activities topped out at $258.7 million in Q3 2024 and bottomed at -$1.5 million in Q3 2025.
• The 4-year median for Other financing activities is $99000.0 (2025), against an average of $28.8 million.
• Biggest YoY gain for Other financing activities was 1288.71% in 2025; the steepest drop was 100.6% in 2025.
• Year by year, Other financing activities stood at $50000.0 in 2023, then jumped by 54.0% to $77000.0 in 2024, then plunged by 2106.49% to -$1.5 million in 2025, then surged by 123.75% to $367000.0 in 2026.
• Per Business Quant, the three latest ZBIO Other financing activities figures stand at $367000.0 (Q1 2026), -$1.5 million (Q3 2025), and $1.7 million (Q2 2025).